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1684-1182/Copyright ª 2014, TaiwanBackground/Purpose: Central-line associated bloodstream infection (CLA-BSI), which is mostly
caused by coagulase-negative staphylococcus, is an important morbidity in neonatal intensive
care units. Our study is aimed to identify the risk factors of CLA-BSI in neonates with periph-
erally inserted central venous catheters (PICCs).
Methods: A retrospective cohort study of neonatal intensive care unit patients with a PICC
insertion between January 1, 2011 and December 31, 2012 was conducted. We performed uni-
variate and multivariate analyses with a logistic regression model to investigate the risk factors
and the association between increased frequency of peripheral venipunctures during PICC use
and the risk of CLA-BSI while adjusting for other variables.
Results: There were 123 neonates included in our study. Thirteen CLA-BSIs were recorded
within the follow-up period. The incidence of PICC-associated CLA-BSI was 4.99 per 1000
catheter-days. There was no statistically significant association between the risk of CLA-BSI
and gestational age, birth weight, chronological age, or other comorbidities. However, the
odds of CLS-BSI increased to 12 times if the patient received six or more venipunctures within
the period without concurrent antibiotic use [odds ratio (OR), 11.94; p < 0.001]. The OR of
CLA-BSIs increased by 16% per venipuncture during PICC use (OR, 1.14; p Z 0.003).ediatric Infectious Diseases, Department of Pediatrics, National Taiwan University Hospital, College of
Number 8, Chung-Shan South Road, Taipei 100, Taiwan.
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Increased venipunctures and risk of infection 231Conclusion: During PICC use, increased frequency of venipunctures, especially when there was
no concurrent antibiotic use, substantially raises the risk of CLA-BSI. By decreasing unneces-
sary venipunctures during PICC use, PICC-associated CLA-BSI and further morbidities and mor-
talities can be prevented.
Copyright ª 2014, Taiwan Society of Microbiology. Published by Elsevier Taiwan LLC. All rights
reserved.Introduction
Hospital-acquired infections (HAIs),whichusually result in the
majority of themortality andmorbidities in the intensive care
unit (ICU) setting, have been a serious problem for the health
care of premature infants. In a survey conducted in theUnited
States, HAIs occurred in about one-tenth of the patients in
neonatal intensive care units (NICUs).1,2 More than 50% ofHAIs
were bloodstream infections, especially central-line associ-
ated bloodstream infection (CLA-BSI).1e3 The attributable
mortality rate of CLA-BSIs in the ICUs ranged from 4% to 20%,4
although the rate may be a little lower in the NICU,5 but the
consequent morbidities and prolonged duration of ICU
admission still accounted for considerable medical costs.4,6
Although older children in the pediatric ICU may have
other types of central lines, for example, double lumen
catheter for renal replacement therapy or catheters for
extracorporeal life support, peripherally inserted central
catheter (PICC) accounts for the majority of central lines in
the NICU because its placement is easier and it has fewer
complications than a traditional central venous catheter.7e10
Many studies has tried to find the possible pathogenesis
and the risk factors of CLA-BSI, but no consensus has been
achieved.11e17 Whereas some researchers argued whether
low bodyweight (either at birth or at the time of catheter
insertion) and the use of total parenteral nutrition
contributed to CLA-BSI,9,11,15,17 recent studies favored the
prolonged duration of PICC use as the most important risk
factor of acquiring CLA-BSIs.13,18
By contrast, about 70e90% of PICC-associated CLA-BSIs
were caused by coagulase-negative staphylococci
(CoNS).11e13,19 Previous researchers considered that intra-
luminal colonization and increased frequency of hub
manipulation might be the main pathogenesis of CLA-
BSIs.12,20 However, these studies had controversial findings
to make a definite explanation, and their conclusion could
not be applied completely to CLA-BSI in patients with
PICCs. As a result, we designed this study to investigate the
risk factors of PICC-associated CLA-BSIs.Methods
Setting and patients
We conducted a retrospective cohort study of patients in the
NICU at the National Taiwan University Hospital (NTUH), a
tertiary-care facility in northern Taiwan. The NICU is a 25-bed
ward admitting about 800e900 patients per year.Most patients
in the NICU were born at the NTUH and admitted to the NICU
soon after birth. The otherswere transferred to the NTUH fromlocal obstetric clinics or other hospitals for more advanced
medical care, for example, surgery for congenital heart
disease.
In the NTUH NICU, a PICC would be inserted to deliver
parenteral nutrition when a patient was not anticipated to
have adequate oral intake at about 1 week after birth.
PICCs were inserted by a skillful and experienced team,
including pediatric residents and neonatologists, according
to the standard protocol with sterile methods.
In this study, we included all the patients who received
at least one PICC placement in the NTUH NICU between
January 1, 2011 and December 31, 2012. The patients
whose PICC insertion was performed at other hospitals prior
to being transferred to NTUH were excluded because we
could not confirm the medical records during the PICC use,
and the setting and the catheter care routine were
different outside the NTUH.
Data collection
The list of patients who had bloodstream infection that
occurred in the NICU was obtained from the database of the
central laboratory of NTUH. CLA-BSI was identified ac-
cording to the surveillance definition of Centers for Disease
Control and Prevention’s National Healthcare Safety
Network for CLA-BSI.21,22
The microorganism of CLA-BSI was cultured with stan-
dard laboratory methods at the central microbiology labo-
ratory of NTUH, and the antibiotic susceptibility profiles
were obtained from laboratory reports.
We reviewed all the medical charts of the eligible pa-
tients and conducted a thorough survey to record the data
on sex, date of birth, gestational age at birth, birth body-
weight, and comorbidities during NICU admission. Data
including the date of PICC insertion and removal, the site of
PICC insertion, the date of antibiotic use and discontinua-
tion, and the frequency of peripheral venipunctures pa-
tients received during PICC use were extracted from
detailed medical records. Gestational age was categorized
as <32 weeks or 32 weeks. Birth weight was categorized
as <1500 g or 1500 g.1,23 Chronological age was grouped
as 7 days or >7 days. The PICC duration was divided into
three groups d 10 days, 11e20 days, and >20 days d in
univariate analysis, and the frequency of peripheral veni-
punctures was grouped as <6 times and 6 times.
Definition
In our study, a CLA-BSI was defined as a primary blood-
stream infection in a patient that had a central line within
the 48-hour period prior to the development of the
232 H.-Y. Cheng et al.bloodstream infection and it was irrelevant to an infection
at another site.21,22 PICC was defined as a peripherally
inserted central venous catheter that terminates at or close
to the heart or in one of the great vessels and it was mainly
used for infusion of intravenous drug or parenteral nutrition
infusion. The PICCs in NTUH NICU were not used for blood
sampling or hemodynamic monitoring.
PICC duration was defined as days from the insertion of
the PICC until one of the following: (1) the date of positive
blood culture regarded as a CLA-BSI; or (2) the date of PICC
removal. We included all the episodes of PICC placement
including those who had multiple PICC placements.
The frequency of venipunctures was calculated as the
sum of (1) the number of times for peripheral venous
catheter insertion, including failed and successful ones,
and (2) the number of times for peripheral venipunctures
for blood drawing, for example, drawing blood for checking
of hemogram or culture from peripheral veins instead of a
central venous catheter or an arterial catheter. Concurrent
antibiotic use meant that the patient was under antibiotic
treatment while the PICC was in place. The PICC duration
without concurrent antibiotic use referred to the period
the patient had a PICC in place without CLA-BSI and did not
receive any antibiotics at the same time, for example,
from the date the antibiotic was discontinued until the
PICC was removed or the date of a positive blood culture
for CLA-BSI.Statistical analysis
We performed a descriptive analysis for the characteristic
of the patient with PICCs. The incidence of PICC-associated
CLA-BSI was measured as infection episodes per 1000
catheter-days. In the univariate analysis, Student’s t test
for continuous variables and Fisher’s exact test forTable 1 Characteristics of patients with PICCs
Total
Patient number 125
Gestational weeka 28.7  0.3
Birth bodyweight (g)a 1102.9  49.0
Chronological age at PICC insertion (d)a 7.5  0.9
ICU duration at PICC insertion (d) 7.6  0.9
Cormobidities (n)
Lung diseasesa 79 (63)
GI diseasesb 16 (13)
CHDc 66 (53)
CNS diseasesd 24 (19)
Hydrops fetalis 4 (3)
Renal failure 8 (6)
a Lung diseases, included respiratory distress syndrome, bronchopul
lung function.
b GI diseases: gastrointestinal diseases, included intestinal perforati
functional disorder of the gastrointestinal tract or prolong the use of
c CHD: congenital heart diseases, included patent ductus arteriosus
d CNS diseases: central nervous system diseases, included intracrania
disorders.
Data are presented as mean  SE or n (%).
CLA-BSI Z central-line associated bloodstream infection; ICU Z in
catheter.categorical variables were used to identify risk factors of
PICC-associated CLA-BSI; then, we used a multivariable
logistic regression model to find the most significant fac-
tors. A two-tailed p < 0.05 was considered statistically
significant. Data were maintained in Microsoft Excel: Mac
2011 (Bellevue, WA, USA) and analyzed using Stata 12.0
(Stata Corp, College Station, TX, USA).
Results
Cases
There were 123 neonates with 129 PICCs inserted from
January 1, 2011 to December 31, 2012. Four PICCs were
excluded. Three patients had irreversible end-stage disease
and the patients’ parents decided to let these three babies
receive only palliative care. They died while their PICCs
were not removed. We excluded these patients because the
patients may have undiscovered PICC-related infection. We
also excluded another patient, who had bloodstream
infection but the isolated pathogen, Enterobacter aero-
genes, was considered to have originated from the gastro-
intestinal tract rather than from the skin. Overall, a total of
125 PICCs were considered eligible for further analysis.
Demography and incidence of CLA-BSI
Among the 125 PICCs, there were 13 CLA-BSIs that occurred
(10.4%). The incidence rate of PICC-associated CLA-BSI was
4.99 infections per 1000 catheter-days. Eleven of the 13
CLA-BSI were caused by CoNS, whereas the other two were
caused by Candida glabrata.
The mean gestational age at birth was 28.7  0.3 weeks
(Table 1). The mean birth weight was 1102.9  49.0 g, and
the mean chronological age at PICC insertion was 7.5  0.9No CLA-BSI CLA-BSI p
112 13
27.7  1.2 28.8  0.4 0.34
1070.7  183.3 1106.6  50.7 0.82
7.4  1.0 8.6  3.2 0.69
7.6  1.0 7.5  2.2 0.95
70 (62) 9 (69) 0.72
13 (12) 3 (23) 0.24
56 (50) 10 (77) 0.07
19 (17) 5 (39) 0.06
4 (3) 0 (0) 0.49
7 (6) 1 (7) 0.84
monary dysplasia, chylothorax and other diseases that may impair
on, necrotizing enterocolitis and other conditions that may cause
parenteral nutrition.
, ventricular septal defect or other congenital cardiac anomalies.
l hemorrhage, intraventricular hemorrhage, epilepsy or other CNS
tensive care unit; PICC Z peripherally inserted central venous
Figure 2. Mean frequency of venipunctures during PICC use
in NICU patients with and without CLA-BSIs. The I bar represents
the 95% confidence interval. CLA-BSIZ central-line associated
bloodstream infection; NICU Z neonatal intensive care unit;
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nological age, and bodyweight at the time of PICC insertion
were all similar between those with or without CLA-BSI.
As for comorbidities, we did not find any significant as-
sociation between CLA-BSI and comorbidities. The excep-
tions were congenital heart disease and central nervous
system (CNS) diseases, which accounted for higher per-
centages in the CLA-BSI group (77% and 39%, respectively).
The mean PICC duration was 20.8  1.2 days. Eight of 13
(62%) CLA-BSIs in patients with PICCs occurred between the
11th day and the 20th day after the PICC insertion. The PICC
duration for those had CLA-BSIs was 19.2  3.0 days, which
was not significantly longer than the duration for those
without CLA-BSI (21.0  1.3 days, p Z 0.63; Fig. 1). If we
excluded the periods with concurrent antibiotics use, the
PICC duration without concurrent antibiotics remained
similar (12.5 days in CLA-BSI group vs. 11.4 days in non-CLA-
BSI group; p Z 0.65; Fig. 1). The total frequencies of pe-
ripheral venipunctures received in both groups were similar
(18.5 times vs. 14.1 times, respectively; pZ 0.31), but the
patients with a PICC-associated CLA-BSI received double
venipunctures than those without CLS-BSI within the pe-
riods without concurrent antibiotic use (11.4 times vs. 5.3
times, respectively; p < 0.001; Fig. 2.)PICCZ peripherally inserted central venous catheter.Risk factors of CLA-BSI
In the univariate analysis, no association between gesta-
tional age, birth weight, chronological age at PICC inser-
tion, and CLA-BSI was found (Table 2). However, patients
who received six or more venipunctures within the periods
without concurrent antibiotic use had almost 12 times the
odds than that of those who received less than six veni-
punctures (odds ratio 11.94; p < 0.001). Here, we chose six
venipunctures as a cutoff value because the mean numberFigure 1. Mean PICC duration during PICC use in NICU pa-
tients with and without CLA-BSI. The I bar represents the 95%
confidence interval. CLA-BSI Z central-line associated blood-
stream infection; NICU Z neonatal intensive care unit;
PICC Z peripherally inserted central venous catheter.of venipunctures within the periods without concurrent
antibiotic use in patients without CLA-BSI was 5.3. We also
used four or five venipunctures as the cutoff, and the re-
sults were similar (odds ratio 12.0 and 7.9, respectively;
both p < 0.001).
As for multivariate logistic regression model, we
analyzed possible risk factors including gestational age,
birth weight, PICC duration without concurrent antibiotic
use, frequency of venipunctures during PICC use without
concurrent antibiotics, congenital heart disease, and CNS
disease. After adjusting all confounding factors, the only
significant risk factor was the frequency of venipunctures
during the periods of PICC use without concurrent antibi-
otics (Table 3). For every one more venipuncture a patient
received, the odds of acquiring a CLA-BSI increased by 16%
(odds ratio, 1.16; p Z 0.003).Discussion
The incidence of PICC-associated CLA-BSI, 4.99 per 1000
catheter-days, was still low in our medical care setting
compared to that reported in previous studies in different
medical settings, but the PICC duration in our study was
longer.11,13,14,18 A possible explanation is that PICCs in the
NTUH NICU were only used for infusion of intravenous drugs
or parenteral nutrition and were not used for hemodynamic
monitoring or blood sampling. This practice reduced the
chance to manipulate the catheter hub and thus decreased
the chance of microorganism invasion.
The onset time of CLA-BSI in patients with PICCs in this
study was similar to that in previous studies, that is, the risk
was highest during the 11th day to the 20th day after PICC
insertion.13,14 Theoretically, if PICC duration was really an
important risk factor, the risk of CLA-BSI should increase
Table 2 Risk factors of CLA-BSIs in NICU patients with PICCs
PICC infection No PICC infection OR 95% CI p
Gestational age
<32 wk 11 90 1
32 wk 2 22 0.74 0.15e3.63 0.71
Birth bodyweight
<1500 g 11 96 1
1500 g 2 16 1.09 0.22e5.42 0.92
Chronological age at PICC insertion
>7 d 9 88 1
7 d 4 24 1.62 0.46e5.80 0.45
PICC site
Upper limbs 10 91 1
Lower limbs 3 21 1.3 0.33e5.17 0.71
Total duration of PICC insertion
10 d 2 26 1
11e20 d 8 30 3.47 0.65e18.6 0.12
>20 d 3 56 0.70 0.11e4.48 0.70
Total venipunctures during PICC insertion
Mean  SE 18.5  3.8 14.1  1.4 0.31
<15 7 72 1
15 6 40 1.54 0.48e4.94 0.46
Venipunctures during PICC insertion without concurrent antibiotic use
Mean  SE 11.4  2.0 5.25  0.6 0.0009*
<6 2 73 1.00
6 11 39 11.94 1.99e53.25 0.0006*
CLA-BSI Z central-line associated bloodstream infection; NICU Z neonatal intensive care unit; OR Z odds ratio; PICC Z peripherally
inserted central venous catheter; SE Z standard error.
234 H.-Y. Cheng et al.proportionally with the prolonged PICC duration. Never-
theless, the findings of previous studies and our research
showed that the incidence beyond the 20th day did not keep
increasing. This trend implied that longer PICC duration
might not completely explain a CLA-BSI.
By contrast, the single lumen design of PICC makes it
more likely to be used for continuous infusion rather than
for blood sampling. This preference suggests that the
source of CoNS in PICC infection comes more possibly from
the skin or mucosa than from the catheter hub. This theory
could be further supported by the observation that CoNS, as
a member of commensal skin flora, was the most common
pathogen isolated in PICC-associated CLA-BSI.14,18,23
As a result, we designed this study, and our hypothesis
was that the prolonged duration resulted in increased
frequency of peripheral venipunctures. With the
increased frequency of peripheral venipunctures, theTable 3 Logistic regression models for risk factors of CLA-BSI i
Gestational age 32 wk
Birth bodyweight 1500 g
Duration of PICC use without concurrent antibiotic use (d)
Venipunctures during PICC use without concurrent antibiotic use
Congenital heart disease
CNS disease
a OR represents the change in odds ratio per day or times.
CI Z confidence interval; CLA-BSI Z central-line associated bloodstr
intensive care unit; OR Z odds ratio; PICC Z peripherally inserted cpossibility of transient bacteremia increased and it was
more likely to cause bacteria colonization on PICC and
subsequent CLA-BSI. That is to say, it is the increased
frequency of venipunctures that raises the risk of CLA-BSI
rather than prolonged PICC duration. Therefore, we
calculated the frequency of venipunctures during PICC
usage, especially when there was no concurrent antibi-
otic use, because concurrent antibiotics decreased the
possibility for bacteria circulating in the blood to colonize
on the catheter.
Interestingly, although the total venipunctures in both
groups were similar, we found that the frequency of veni-
punctures, when there was no concurrent antibiotic use,
increased significantly in those with CLA-BSI (11.4 times vs.
5.6 times, respectively). The risk for CLA-BSI in those with
six or more venipunctures also increased to almost 12
times.n NICU patients with PICCs




(times) 1.16a 1.05e1.26 0.003
3.17 0.73e13.87 0.13
3.53 0.92e13.56 0.07
eam infection; CNS Z central nervous system; NICU Z neonatal
entral venous catheter.
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explain why some patients with much longer PICC indwelling
did not acquire a CLA-BSI because they usually received
prolonged antibiotic treatment at the same time and actu-
ally had less venipunctures within the PICC duration without
concurrent antibiotic use. The most common concurrent
antibiotic regimens during PICC use in our study were van-
comycin plus ceftazidime, ampicillin plus cefotaxime, and
ampicillin plus gentamicin. In total, of the 13 CLA-BSI cases,
there was only one patient receiving concurrent antibacte-
rial antibiotics while he acquired Candida glabrata CLA-BSI.
The other CLA-BSI case caused by Candida glabrata did not
receive any antibiotics at the same time. Whether the
concurrent antibiotic use increases fungal CLA-BSI is diffi-
cult to confirm because of the low incidence of fungal CLA-
BSI. However, our findings would favor the avoidance of
unnecessary venipunctures rather than the increase of
concurrent antibiotic use to prevent a PICC-associated CLA-
BSI. Prolonged concurrent antibiotic use with increased
frequency of venipunctures may raise the risk of CLA-BSIs
caused by resistant strains or fungus in the long run.
We also analyzed other risk factors of CLA-BSI in patients
with PICCs. Most of them, for example, gestational age,
birth bodyweight, or chronological age at PICC insertion,
did not significantly correlate to CLS-BSI. Although these
factors had been claimed to associate with CLS-BSI,9,11,15
further studies did not show lower birth weight or smaller
gestational age to be the consistent risk factor of CLA-BSI in
patients with PICCs.13,14,18 Our study was consistent with
this controversy.
In addition, our study revealed there were more patients
with CLA-BSIs having congenital heart diseases or CNS dis-
eases. The most common congenital heart disease was
Patent ductus arteriosus, whereas the most common CNS
disease was intraventricular hemorrhage. This observation
also supported our hypothesis because a Patent ductus
arteriosus might cause a right-to-left shunt, which helped
the circulating microorganism in the blood to escape from
the filtration of pulmonary circulation and allowed the
transient bacteremia to persist longer in systemic circula-
tion. Unstable hemodynamics also increased the risk of
intraventricular hemorrhage.
The major indications of peripheral venipunctures in our
study included intravenous drug infusion, inotropics, blood
transfusion, and calcium or albumin supplement. Most of
them can be avoided, for example, by using the oral form of
drugs instead of using intravenous forms. Our findings sup-
ported the recommendation of declining unnecessary
intravenous catheter insertion and blood sampling. By
reducing unnecessary peripheral venipunctures, doctors
are able to substantially reduce the chances of PICC-
associated CLA-BSI.
There are several limitations in our study. First, our
study was a retrospective study and depended on medical
records to calculate the frequency of venipunctures, and
this might be underestimated if the medical staff did not
record the frequency of venipunctures correctly. This sit-
uation occurred most possibly when a patient received too
many venipunctures at the same time. Second, we did not
perform further laboratory tests, for example, genetic
typing, to identify if the microorganism isolated from blood
was the same as that on the skin flora. Third, the samplesize of our cohort and the case number of CLA-BSI in pa-
tients with PICCs were not very large. However, the results
of our study were still statistically significant. Finally, our
study can only explain those CLA-BSIs caused by commensal
skin flora, which accounted for about 70% to 90% of all-
cause CLA-BSIs.11,12
In conclusion, our study demonstrates the association of
peripheral venipunctures and CLA-BSIs in patients with
PICCs. The findings of our study contribute not only to
clarify the possible pathogenesis and the origin of micro-
organism of CLA-BSI but also to help develop preventive
measures against HAIs in the NICU.
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